The Global Burden of Diabetic Kidney Disease: Time Trends and Gender Gaps
- 160 Downloads
Purpose of Review
Diabetes mellitus prevalence is increasing throughout the world as a consequence of growing rates of obesity, metabolic syndrome, and westernization of lifestyle. It is currently unknown to what extent these trends affect the global burden of diabetic kidney disease (DKD). This review seeks to describe the global burden of DKD and how it has changed throughout time using recently released results of the Global Burden of Disease 2017 Study.
DKD prevalence has remained fairly stable at the global level and among many world regions since 1990. At the global level, the proportion of DKD deaths relative to other types of CKD is increasing.
Certain world regions still have very high rates of DKD, whereas other world regions have decreasing prevalence and mortality. Screening will likely play an important role in mitigating the growing burden within high-risk regions.
KeywordsDiabetic nephropathy Global burden of diabetic kidney disease Gender and diabetic kidney disease
Compliance with Ethical Standards
Conflict of Interest
The author declares that she has no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by the author.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 3.Giorda CB, Carna P, Salomone M, Picariello R, Costa G, Tartaglino B, et al. Ten-year comparative analysis of incidence, prognosis, and associated factors for dialysis and renal transplantation in type 1 and type 2 diabetes versus non-diabetes. Acta Diabetol. 2018;55(7):733–40. https://doi.org/10.1007/s00592-018-1142-y.CrossRefPubMedGoogle Scholar
- 4.•• Collaborators GBDRF. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1923–94. https://doi.org/10.1016/S0140-6736(18)32225-6. Most recent update to the Global Burden of Disease Study which describes the effects of 84 risk factors on loss of health and life throughout the world for time periods between 1990 and 2017. CrossRefGoogle Scholar
- 5.•• Collaborators GBDCoD. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1736–88. https://doi.org/10.1016/S0140-6736(18)32203-7. Most recent update to the Global Burden of Disease Study which ranks causes of death throughout the world for time periods between 1990 and 2017. This study includes chronic kidney disease and CKD subtypes. CrossRefGoogle Scholar
- 10.Disease GBD, Injury I, Prevalence C. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the global burden of Disease study 2017. Lancet. 2018;392(10159):1789–858. https://doi.org/10.1016/S0140-6736(18)32279-7.CrossRefGoogle Scholar
- 11.Dagenais GR, Gerstein HC, Zhang X, McQueen M, Lear S, Lopez-Jaramillo P, et al. Variations in diabetes Prevalence in low-, middle-, and high-income countries: results from the prospective urban and rural epidemiological study. Diabetes Care. 2016;39(5):780–7. https://doi.org/10.2337/dc15-2338.CrossRefPubMedGoogle Scholar
- 14.Kume S, Araki SI, Ugi S, Morino K, Koya D, Nishio Y, et al. Secular changes in clinical manifestations of kidney disease among Japanese adults with type 2 diabetes, 1996-2014. Journal of diabetes investigation. 2018. https://doi.org/10.1111/jdi.12977.
- 17.COMMITTEE SRRA. Singapore Renal Registry Annual Report 2016 2018. https://www.nrdo.gov.sg/docs/librariesprovider3/default-document-library/singapore-renal-registry-annual-report-2016_1999-till-2016_v5_online_final.pdf?sfvrsn=0
- 18.Stel VS, Awadhpersad R, Pippias M, Ferrer-Alamar M, Finne P, Fraser SD, et al. International comparison of trends in patients commencing renal replacement therapy by primary renal disease. Nephrology. 2018. https://doi.org/10.1111/nep.13531.
- 19.van den Donk M, Sandbaek A, Borch-Johnsen K, Lauritzen T, Simmons RK, Wareham NJ, et al. Screening for type 2 diabetes. Lessons from the ADDITION-Europe study. Diabetic medicine: a journal of the British Diabetic Association. 2011;28(11):1416–24. https://doi.org/10.1111/j.1464-5491.2011.03365.x.CrossRefGoogle Scholar
- 20.Sargeant LA, Simmons RK, Barling RS, Butler R, Williams KM, Prevost AT, et al. Who attends a UK diabetes screening programme? Findings from the ADDITION-Cambridge study. Diabetic medicine: a journal of the British Diabetic Association. 2010;27(9):995–1003. https://doi.org/10.1111/j.1464-5491.2010.03056.x.CrossRefGoogle Scholar
- 21.Simmons RK, Griffin SJ, Lauritzen T, Sandbaek A. Effect of screening for type 2 diabetes on risk of cardiovascular disease and mortality: a controlled trial among 139,075 individuals diagnosed with diabetes in Denmark between 2001 and 2009. Diabetologia. 2017;60(11):2192–9. https://doi.org/10.1007/s00125-017-4299-y.CrossRefPubMedPubMedCentralGoogle Scholar
- 27.Krishnan A, Chandra Y, Malani J, Jesudason S, Sen S, Ritchie AG. End-stage kidney disease in Fiji. Intern Med J. 2018. https://doi.org/10.1111/imj.14108.
- 30.• Carrero JJ, Hecking M, Chesnaye NC, Jager KJ. Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease. Nature reviews Nephrology. 2018;14(3):151–64. https://doi.org/10.1038/nrneph.2017.181. One of the few studies to take an in-depth look at possible ways in which gender plays a role in kidney disease incidence and progression. CrossRefPubMedGoogle Scholar
- 32.Saran R, Li Y, Robinson B, Abbott KC, Agodoa LY, Ayanian J, et al. US Renal Data System 2015 Annual Data Report: Epidemiology of Kidney Disease in the United States. American journal of kidney diseases: the official journal of the National Kidney Foundation. 2016;67(3 Suppl 1):Svii, S1–305. https://doi.org/10.1053/j.ajkd.2015.12.014.CrossRefGoogle Scholar
- 33.United States Renal Data System. 2018 USRDS annual data report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2018Google Scholar
- 36.Komenda P, Ferguson TW, Macdonald K, Rigatto C, Koolage C, Sood MM, et al. Cost-effectiveness of primary screening for CKD: a systematic review. American journal of kidney diseases: the official journal of the National Kidney Foundation. 2014;63(5):789–97. https://doi.org/10.1053/j.ajkd.2013.12.012.CrossRefGoogle Scholar
- 37.Black C, Sharma P, Scotland G, McCullough K, McGurn D, Robertson L, et al. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis. Health Technol Assess. 2010;14(21):1–184. https://doi.org/10.3310/hta14210.CrossRefPubMedGoogle Scholar
- 38.Moyer VA. Force USPST. Screening for chronic kidney disease: U.S. preventive services task force recommendation statement. Ann Intern Med. 2012;157(8):567–70. https://doi.org/10.7326/0003-4819-157-8-201210160-00533.CrossRefPubMedGoogle Scholar